Comparison of acupotomy release combined with glucocorticoid intrathecal injection versus isolated glucocorticoid intrathecal injection for carpal tunnel syndrome: A protocol for a meta-analysis of comparative studies. Issue 9 (3rd March 2023)

• Record Type: Journal Article
• Authors: Liu, Yukun; Yang, Jingfan; Dong, Wei; Liu, Weitong; Chen, Li; Li, Jiao; Chen, Jiankun; Zhou, Xing; Yin, Hong; Li, Jinlei
• Is Part Of: Medicine. Volume 102:Issue 9(2023)
• Page Start: e32940
• Publication Date: 2023-03-03
• Subjects: acupotomy release -- carpal tunnel syndrome -- glucocorticoid intrathecal injection -- protocol -- small needle knife; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000032940
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Background: Carpal tunnel syndrome (CTS) is more common in people who need to engage in repetitive wrist work. Once it has occurred, localized pain and numbness of the fingers will develop, in severe cases, muscle atrophy will even arise, and after rest and physical therapy, many patients will still be unable to relieve or recur. In this case, the patient can receive intrathecal glucocorticoid injections, but the hormone injections alone can only provide short-term relief, and because the mechanical factors of median nerve compression are not fundamentally removed. Therefore, combined acupotomy release can help to release the compression of the transverse carpal ligament on the nerve and increase the volume within the carpal tunnel to achieve more satisfactory long-term results. Hence, a meta-analysis is necessary to provide evidence whether there is a significant difference in the treatment of CTS with acupotomy release combined with glucocorticoid intrathecal injection (ARGI) compared with isolated glucocorticoid intrathecal injection (GI). Methods: We will search, with no time restriction, without any restriction of language and status, the time from the establishment of the database to October 2022, on the following databases: PubMed, Cochrane central register of controlled trials, Web of Science, Chinese national knowledge infrastructure, Wanfang data, Chinese scientific journals database, Chinese databases SinoMed, and electronic databases. The electronic database search will be supplemented by a manual search of the reference lists of included articles. We will apply the risk-of-bias tool of the Cochrane collaboration for randomized controlled trials to assess the methodological quality. Risk-of-Bias Assessment Tool for nonrandomized studies was used to evaluate the quality of comparative studies. Statistical analysis will be conducted using RevMan 5.4 software. Results: This systematic review will evaluate the difference in efficacy of ARGI versus isolated GI in the treatment of CTS. Conclusion: The conclusion of this study will provide evidence for judging whether ARGI is superior to GI for treatment of CTS.